Furthermore, FDA is proposing two other constraints about the submission of a supplemental PMTA. Under proposed § 1114.fifteen(a), a supplemental PMTA could not be submitted exactly where the advertising and marketing get for the initial tobacco item has long been withdrawn or is briefly suspended or is the subject of momentary suspension or wit